In the latest instalment of Platforce’s “Pharma Insights,” industry leaders from across the globe gathered to discuss the transformative power of Customer Relationship Management (CRM) and Artificial Intelligence (AI) within the pharmaceutical sector. Moderated by Juliana Kreisel, Event Manager at Platforce, and Stefan Repin, Head of Marketing at Platforce, the webinar delved into the unique approaches and challenges faced by different regions in implementing these technologies.
Insights from Global Leaders
Sanjay Choubey, VP and CIO/CDO (North America) at Dr. Reddy’s Laboratories, highlighted the evolution of CRM systems from transactional tools to strategic platforms through the integration of AI. He explained, “AI has opened the possibility of moving from transactional to strategic engagements. We now look at the customer’s life 360 degrees to tailor our approaches and interactions.”
Stefan Turnwald, Founder & CEO, representing Europe, shared a historical perspective on CRM and AI, questioning whether these tools enable representatives or micromanage them. He emphasized the importance of using AI to empower rather than control, stating, “The real question is whether we are ensuring the right message is delivered or if we are establishing a platform for trusted communication.”
Alex Sanghikian, Digital Business, CRM, Data & Innovation Manager at Sandoz, discussed the challenges and opportunities in Latin America. He pointed out, “One of the main challenges in implementing AI in CRM is managing the large amounts of data required to feed these systems effectively, ensuring compliance and data privacy.”
Engaging Discussions on Future Trends
The panel also explored future trends in digitalization and their potential impact on the pharmaceutical industry. Discussions revolved around how AI is reshaping customer engagement strategies, with a focus on creating more personalized and efficient interactions.
Sanjay Choubey shared insights on using AI to enhance customer interactions, “We track everything in a customer’s life to make our conversations as relevant as possible. This tailored approach is what makes AI an invaluable part of our CRM strategy.”
Key Takeaways and Regional Perspectives
The webinar provided a comprehensive overview of how different regions are leveraging CRM and AI to advance their digital transformation agendas. From enhancing customer engagement to streamlining operations, the insights shared by the panellists painted a vivid picture of a sector on the cusp of significant technological advancements.
Alex Sanghikian specifically highlighted the importance of adapting to regional nuances, “In Latin America, the customization of communication and understanding customer behaviour is crucial in utilizing AI effectively.”
Conclusion
“Regional Digitalization Strategies: CRM and AI in LATAM, Europe, and the US” offered a deep dive into the strategic use of technology in the pharmaceutical industry, illustrating the diverse approaches and common challenges faced by professionals across the globe. This episode of Pharma Insights not only provided valuable learning opportunities but also sparked conversations about the future of digitalization in pharma.
For those interested in exploring the detailed discussions and gaining deeper insights, the full webinar is available here.
This blog post encapsulates the discussions from the recent Pharma Insights webinar, providing a snapshot of how digital tools like CRM and AI are being tailored to meet the needs of the pharmaceutical industry across different global markets.
In the rapidly evolving pharmaceutical landscape, Go-To-Market (GTM) strategies are increasingly essential for market success. A recent webinar hosted by Platforce, moderated by Juliana Kreisel, Events Manager, and Stefan Repin, Head of Marketing, provided a comprehensive exploration of how GTM strategies are enhanced through omnichannel approaches. The panel included seasoned experts like Chiara Bolognini from Roche, Chris Wade from Exeevo, Morgwn Shaw from Bristol Myers Squibb, and Susana Bento from Grünenthal.
In-Depth Insights on Omnichannel Integration in GTM Strategies
The discussion revolved around key aspects of integrating omnichannel strategies within GTM models, emphasizing the necessity of adapting global strategies to meet local market demands effectively.
Localizing Global Strategies
Chiara Bolognini stressed the importance of customizing global strategies to local contexts. She advocated for a co-creation model, stating, “Although you have a global omnichannel initiative, the last steps of the action must always be local.” This approach ensures that global strategies are not only relevant but also resonate deeply with local market needs.
Adapting and Measuring Effectiveness Locally
Chris Wade explored the challenges of measuring and adapting the effectiveness of local engagements within a global framework. He noted the importance of collaborative creation, saying, “It’s always tricky to find the right model… What I see working really well is having this co-creation and having clear KPIs.” This strategy facilitates alignment between local and global initiatives, allowing for necessary adjustments based on real-time data.
Integrating Local Insights
Morgwn Shaw highlighted the crucial role of local insights in global campaigns. He explained, “We see much more compliance because what comes into the market has the fingerprints of the market all over it.” By incorporating local nuances, global campaigns become more applicable and effective, enhancing overall engagement.
Technology’s Role in Enhancing Engagement
Susana Bento emphasized how technology facilitates the adaptation of global strategies, making them more efficient and impactful across markets. “We need some sort of global synergies to make sure we are also more efficient,” she remarked, underscoring how technological solutions streamline processes and improve engagement.
Highlights and Key Topics Discussed
The webinar delved into several important topics:
Strategic Local Adaptation: The necessity for global strategies to be adaptable at the local level to ensure relevance and effectiveness.
Effective Measurement and Adaptation: The importance of establishing clear KPIs to track the success of localized strategies and make necessary adjustments.
The Integration of Technology and Insights: How integrating local insights and technological advancements can enhance the impact of global campaigns.
Enhancing Engagement Through Technology: Discussing the role of technology in supporting the adaptation and execution of global strategies across diverse markets.
Conclusion: Enhancing Market Success Through Omnichannel Strategies
The panellists concurred on the significant role of omnichannel strategies in the successful deployment of GTM models in the pharmaceutical industry. By leveraging these strategies, companies can achieve more effective market penetration and overall success, ensuring that they meet the evolving demands of healthcare professionals and patients alike.
This dynamic discussion provided actionable insights into the integration of omnichannel frameworks with GTM strategies, highlighting the crucial role of local customization in achieving global success in the rapidly changing pharmaceutical landscape. This webinar serves as a valuable resource for pharmaceutical professionals seeking to enhance their GTM strategies through innovative omnichannel approaches.
The realm of pharmaceuticals is rapidly evolving, propelled by advancements in artificial intelligence (AI). A recent webinar hosted by Platforce, moderated by Juliana Kreisel, Events Manager, and Stefan Repin, Head of Marketing, delved into this topic with insights from esteemed industry leaders. The panel included:
Marco Andre, Global Head of Marketing & Gen AI Excellence at Novartis.
Manuel Mitola, MBA, Sr. Manager of Omni-channel Marketing and Digital Transformation.
Florent Edouard, SVP, Global Head of Commercial Excellence at Grünenthal Group.
Strategic Deployment of AI for Pharma Marketing and Sales Excellence
Marco Andre opened the discussion by emphasizing AI’s pivotal role in refining go-to-market strategies, stating, “AI helps us understand and refine our go-to-market strategies, making them more dynamic and responsive to real-time market conditions.” His insights highlighted the necessity of AI in adapting to rapidly changing environments and ensuring sustained commercial success.
Manuel Mitola discussed the impact of AI on omni-channel marketing, pointing out the speed and efficiency it introduces: “AI dramatically enhances our ability to process data and generate insights, allowing us to be more agile and responsive in our marketing efforts.” His observations underscored the potential for AI to revolutionize marketing strategies by providing deeper, actionable insights at an unprecedented pace.
The Evolving Role of Medical Science Liaisons in an AI-Driven Era
Florent Edouard addressed the changing landscape for Medical Science Liaisons (MSLs), noting their increased reliance on AI for delivering timely data to healthcare professionals. “MSLs are increasingly relying on AI to provide timely and relevant data to healthcare professionals, enhancing the overall communication and effectiveness of pharmaceutical marketing,” he explained. This shift highlights the critical role of AI in bridging the gap between clinical developments and market needs.
Insights from the Experts
During the webinar, Marco Andre also touched upon the challenges of implementing AI, noting the resistance that sometimes arises within organizations: “The integration of AI allows us to engage with healthcare professionals on various digital platforms, optimizing our interaction based on their preferences and behaviors,” illustrating the personalized approach AI facilitates.
Florent Edouard further elaborated on the practical applications of AI in creating targeted marketing strategies: “AI’s ability to analyze large datasets allows us to identify key trends and opportunities in the market, which can then be leveraged to tailor our strategies more effectively,” he shared.
Empowering Pharma Professionals with AI Insights
This webinar provided a comprehensive exploration of AI’s role in transforming commercial strategies in the pharma industry. The detailed discussions and case studies presented by the panelists offered actionable insights for industry professionals eager to harness AI technologies to enhance their operational strategies.
For a deeper dive into these discussions, the full webinar can be accessed at Platforce’s webinar page.
The session not only highlighted the benefits and challenges of adopting AI in the pharmaceutical industry but also provided a roadmap for organizations looking to leverage AI for commercial excellence. The blend of expert opinions and practical examples presented a valuable resource for industry professionals aiming to integrate AI into their commercial strategies effectively.
In the realm of pharmaceuticals, customer experience (CX) may not have its Olympic games, but the stakes are just as high. Platforce’s recent webinar, moderated by Stefan Repin and Juliana Maria Kreisel, explored this competitive arena, focusing on how companies can excel in CX. The panel included:
Michelle Bridenbaker shared insights into integrating AI and maintaining a human touch in CX strategies. She emphasized the importance of balancing technological advances with human-centric service, noting, “Perfection only happens when you fall so many times and figure out how to get up. It’s about recovering from those falls and improving.”
Alex Jijie, CEO of Digitalya, discussed the challenges and rewards of implementing digital transformations within the pharma industry. He highlighted the importance of adapting to changing customer needs and the role of digital tools in enhancing customer interactions.
Mehrnaz Campbell addressed the shifting landscape of social media and its impact on CX. She pointed out, “Sometimes in working in pharma, we’re seeking perfection, but perfection is achieved through learning from failures and continuous improvement.”
Measuring Success in CX
The webinar explored various metrics for measuring the success of CX initiatives. From traditional KPIs to innovative methods like social listening, the discussion underscored the need for metrics that reflect real improvements in customer satisfaction and engagement.
Building a Customer-Centric Culture
Creating a customer-centric culture within pharma was a major theme. Speakers shared strategies for embedding customer-focused values at all levels of an organization, ensuring that every team member understands and contributes to the overarching goal of exceptional customer service.
Leveraging Digital Advancements
With advancements in AI and digital platforms, pharma companies have new tools at their disposal to enhance CX. The panel discussed the integration of these technologies into existing frameworks, ensuring they complement rather than complicate the customer journey.
Conclusion
The “Olympic-Level Customer Experience in Pharma” webinar provided valuable insights into the evolution of CX in the digital age. As companies strive to enhance their customer interactions and stay ahead of trends, the lessons shared by industry leaders like Bridenbaker, Jijie, and Campbell offer guidance and inspiration for navigating this dynamic field. With the right strategies and tools, any pharma company can aspire to a gold-medal-worthy customer experience.
In a recent enlightening episode of “Pharma Insights,” hosted by Platforce, the conversation turned towards the sweeping changes digital media and omnichannel strategies are bringing to the pharmaceutical industry. Moderated by Juliana Kreisel and Stefan Repin, this webinar brought together industry luminaries to delve into how these strategies are reshaping the way pharmaceutical companies engage with healthcare professionals (HCPs) and patients.
Leveraging Omnichannel for Deeper Engagement
José Ma. (Chema) Guido Avila, Global Dupixent Patient Experience Lead at Sanofi, opened the discussion by emphasizing the strategic nature of omnichannel approaches. He remarked, “Effective omnichannel strategies are not just about spreading across multiple platforms but about creating meaningful, context-driven interactions that enhance the customer journey at every touchpoint.” This perspective highlights the shift from traditional, one-dimensional customer interactions to a more integrated, holistic approach to patient and HCP engagement.
Tomasz Piotrowski, Head of Medical Affairs Innovation Lab at Novartis, further elaborated on the transformative role of digital media within these strategies. “By integrating digital media, we can ensure that the customer journey is not only seamless across all platforms but also richly informative and engaging,” he stated, underscoring the importance of digital integration in creating compelling customer experiences.
Discussion Highlights: Innovations and Challenges
The panel explored several areas where digital strategies are making significant impacts:
Revolutionizing Communication: The conversation highlighted how omnichannel strategies are transforming interactions with both HCPs and patients by enabling more dynamic and interactive engagements.
Innovative Patient Engagement Approaches: Examples from industry leaders illustrated how digital tools are being used to improve patient experiences and outcomes, providing insights into successful strategies currently in use.
Navigating Implementation Challenges: The experts discussed the hurdles companies face when implementing these strategies, such as the integration of diverse digital tools and maintaining a cohesive strategy across various channels.
Integrating Digital Tools: A Strategic Imperative
Both speakers shared insights on the critical integration of digital tools into omnichannel strategies, not as mere additions but as fundamental components that enhance and refine the quality of engagement. Chema noted the importance of these strategies being where it matters most to the patient, effectively meeting their needs with precision and empathy.
Tomasz highlighted the enhanced customer experience through digital media, pointing out that these tools offer a significant upgrade over traditional methods by enriching the interaction landscape. He commented on the potential of digital media to transform the entire communication strategy, making it more responsive to customer needs and expectations.
Conclusion
The episode of “Pharma Insights” offered a deep dive into the strategic use of digital media and omnichannel strategies in the pharmaceutical industry, illustrating the diverse approaches and common challenges faced by professionals. As the industry continues to evolve with these technological advancements, the insights from this webinar provide valuable guidance for leveraging these tools to foster better engagement with HCPs and patients.
For those interested in further exploring the discussion and hearing more from the experts, the full webinar is available here.
This blog post captures the essence and key takeaways from the “Digital Media in Pharma: The Rise of Omnichannel” webinar, providing a comprehensive overview for pharmaceutical professionals on how to effectively integrate and optimize digital tools and omnichannel strategies in their engagement efforts.
AI in pharma commercial excellence is a subject that is gathering much interest. In the ever-evolving landscape of the pharmaceutical and life sciences sectors, the application of artificial intelligence (AI) is fundamentally transforming approaches to commercial excellence. A recent webinar hosted by Platforce brought together the following speakers to discuss these innovations:
Muhammad Sajjad, Deputy Director of Commercial Excellence & Trade Marketing at OBS AGP Pvt. Ltd.
Mohamed Amer, a seasoned Commercial Operations Business Excellence Expert,
The session was expertly moderated by Juliana Kreisel, Events Manager, and Stefan Repin, Head of Marketing at Platforce.
Key Challenges and AI Solutions for Sales Efficiency
The webinar delved into several critical challenges currently faced by the pharma industry, including stringent regulations, healthcare professional (HCP) engagement, consent management, and the need for effective KPI tracking. AI-driven tools offer novel solutions to these challenges by enhancing the precision and efficiency of marketing campaigns and customer interactions.
One of the highlights was a discussion on hyper-personalization, a strategy facilitated by AI that allows companies to tailor their interactions with healthcare professionals meticulously. This approach ensures that marketing efforts are more aligned with the needs and preferences of HCPs, leading to improved engagement and compliance.
Case Studies and Real-world Applications of AI in Sales
Throughout the webinar, we illustrated how AI tools have successfully been implemented to enhance commercial excellence through sharing practical case studies. These examples showcased AI’s capability in data analysis, prediction, and strategy formulation, providing attendees with actionable insights companies could consider implementing in their operations.
The Role of Medical Science Liaisons
A significant portion of the discussion highlighted the evolving role of medical science liaisons (MSLs) in the era of AI. These professionals are crucial in bridging the gap between clinical developments and clinical practice, providing in-depth scientific knowledge that supports the safe and effective use of pharmaceutical products.
Expert Insights on AI in Pharma Commercial Excellence
Muhammad Sajjad emphasized the sophisticated nature of sales force effectiveness (SFE) in the pharma industry, noting, “SFE is defined by metrics that measure the effectiveness of the medical rep’s sales activities. AI helps refine these metrics, leading to better strategy and territory management.”
Mohamed Amer discussed the shift towards digital engagement, explaining how AI facilitates a multi-channel approach that meets HCPs where they are most receptive. “The integration of AI allows us to engage with healthcare professionals on various digital platforms, optimizing our interaction based on their preferences and behaviours,” Amer elaborated.
Conclusion
The webinar on “Commercial Excellence in the Era of AI” provided pharmaceutical professionals with a comprehensive overview of how AI can revolutionize their field. The insights from Muhammad Sajjad and Mohamed Amer highlighted the potential of AI in overcoming traditional challenges and opened up a dialogue on future innovations that could continue to drive the industry forward.
This exploration into AI in pharma commercial excellence underscores a pivotal shift towards more data-driven, personalized, and efficient practices that promise to reshape the landscape of healthcare marketing and sales strategies.
For those interested in gaining deeper insights into how AI is reshaping the pharmaceutical landscape, the full webinar is available on Platforce’s dedicated webinar page. This resource offers an invaluable opportunity for industry professionals to learn directly from leading experts and explore AI’s potential in enhancing their operational strategies.
In the ever-evolving pharmaceutical sector, the transition from traditional rep-centric to innovative content-centric customer relationship management (CRM) systems signifies a pivotal shift. A recent webinar hosted by Platforce provided a deep dive into this transformation, featuring insights from leading industry experts. Moderated by Juliana Kreisel and Stefan Repin from Platforce, the session included discussions with Chris Wade from Exeevo, Philip Vyt from Growth for Pharma, and Florent Edouard from Grünenthal Group.
Key Highlights and Topics Discussed
The webinar addressed several crucial aspects of CRM strategies in the pharmaceutical industry:
The Evolution from Rep-Centric to Content-Centric CRM:
Chris Wade detailed the transformation driven by Veeva Vault CRM, emphasizing the shift towards leveraging content to engage healthcare professionals more effectively. He explained, “It’s about engaging healthcare professionals with targeted content that resonates with their daily needs and challenges.”
Strategic Implications of Advanced CRM Integration:
Philip Vyt discussed the strategic importance of integrating platforms like Veeva Vault to enhance CRM capabilities beyond simple relationship management. “This evolution is a strategic necessity to enhance how relationships are managed and to utilize content to make those relationships more impactful,” Vyt highlighted.
Global Implementation Challenges:
Florent Edouard provided insights on the global deployment of these sophisticated CRM tools, focusing on the challenge of adapting strategies to align with local market nuances while maintaining global strategic objectives.
The Shift to Content-Centric Strategies
The discussion underscored that modern CRM systems in pharma must transcend their traditional roles. They need to become robust tools that do not merely store information but actively facilitate and enhance engagement with tailored relevant content.
Chris Wade emphasized the growing need for CRM systems to support dynamic content strategies: “We’re not just talking about sales rep interactions anymore. It’s about delivering precise content at the right time that addresses the specific challenges and needs of healthcare professionals.”
Philip Vyt elaborated on the necessity of these systems to integrate seamlessly with other digital marketing tools to provide a unified customer experience across all touchpoints.
Florent Edouard discussed the operational aspect, highlighting the importance of ensuring these CRM systems are versatile enough to meet diverse regulatory environments and market demands without compromising on the strategic vision.
Conclusion: The Future of Pharma CRM
The session wrapped up with a forward-looking perspective on the role of CRM systems in pharma. The industry experts agreed that the future of pharma CRM lies in its ability to integrate deeply with digital marketing strategies, focusing on delivering value through high-quality, engaging content.
The insights from the webinar highlighted the current trends and paved the way for companies to harness these new tools for improved outcomes in CRM endeavours. As the industry continually adapts to these changes, the guidance of our webinar guests will undoubtedly serve as a valuable blueprint for pharmaceutical companies looking to stay competitive in an increasingly digital and content-driven marketplace.
This blog post aims to encapsulate the rich dialogue and essential takeaways from the webinar, providing a comprehensive overview for pharmaceutical professionals about the strategic transition towards content-centric CRM strategies.
Just like flexibility in pricing, the pharmaceutical industry has proven to be an essential component of modern society, especially in recent years. It is responsible for the research, development, manufacturing, and marketing of drugs that help people live longer and healthier lives. However, in 2025, pharma companies are cutting down budgets on CRM. This news may seem daunting for many companies, but it presents an opportunity for others.
One such company is Platforce, a CRM+CLM product company. Instead of worrying about the current market trend, the CEO of Platforce, Artem Brytchenko has taken a more positive outlook, believing that the company will benefit from the current trend. The reason behind this positive outlook is the flexibility that the company offers in its pricing model.
Platforce offers tailored CRM solutions that are very competitive on the market when it comes to pricing. The company can easily add or take away certain features, making it much more flexible when setting a price. This flexibility is something that many big corporations cannot afford, giving Platforce an edge in the market. The tailored solutions that Platforce offers also provide an added advantage. The company can customize its CRM services to suit the specific needs of the client.
The pharmaceutical industry is not the only one affected by the current market trend. Many companies across industries are cutting down on their CRM budgets. In such a situation, companies are looking for cost-effective solutions that can provide the necessary services without breaking the bank. This is where Platforce comes in, providing tailored solutions at competitive prices.
By offering customized CRM solutions, Platforce is also better equipped to meet the changing demands of the market. This is because the company can adjust its services according to the client’s changing needs, ensuring that it stays relevant and up-to-date with the latest trends. For instance, if a company wants to focus more on digital marketing, Platforce can adjust its services to help the company achieve this goal.
The benefits of flexibility in pricing and tailored solutions do not end there. Companies that offer such services are also better equipped to meet the unique needs of their clients. By understanding the client’s specific requirements, Platforce can provide solutions that are not only cost-effective but also relevant and useful. This, in turn, leads to increased customer satisfaction and loyalty, as the client knows that they are getting a service that is tailored to their needs.
As the market trend for reduced CRM budgets continues, companies like Platforce may even see an increase in demand for their services. This is because more and more companies will be looking for cost-effective solutions that can provide the necessary services without compromising quality. With its flexible pricing and tailored solutions, Platforce is well-positioned to meet this demand.
It is important to note that the market trend for reduced CRM budgets is not the end of the world for CRM companies. Instead, it presents an opportunity for companies to adapt and evolve to meet the changing demands of the market. By offering tailored solutions at competitive prices, companies can stay ahead of the game and even benefit from the current trend.
In conclusion, the pharmaceutical industry’s reduced CRM budgets present an opportunity for CRM companies to differentiate themselves from the competition. By offering flexibility in pricing and tailored solutions, companies like Platforce can provide cost-effective solutions that meet the unique needs of their clients. As the market evolves, it is crucial for companies to remain adaptive and take advantage of the opportunities presented to them.
Pharma conferences are more than just professional gatherings; they allow companies to network, create business opportunities, learn new information, and stay ahead in the industry. However, these pharmaceutical events require commitments and consume time and money. Hence, one must actively participate to yield substantial results from investments.
As a regular participant or a first-timer, there are different strategies pharmaceutical and life science companies can use to get the full benefits of these conferences. It involves defining your goals before the conference and engaging other attendees using various means.
Additionally, it is essential to follow up on new contacts in person and remotely using Platforce CRM software to ensure long-term relationships after the conference. This article will explore creative strategies to help you leverage the potential of pharma conferences in the best manner and give tips on tracking the outcomes of your marketing efforts in the healthcare system.
How to Prepare for Pharmaceutical Sciences Conferences in 2025
Different pharmaceutical sciences fields, such as pharmacology, drug discovery, clinical research, and pharmaceutical marketing, organize conferences annually. It’s not every local and international conference a pharma industry should attend because not all will meet your needs.
The first step to maximize pharma conferences is to attend events that share the same values as your professional, scientific organization.
Before the d-day, it is essential to prepare adequately so everything goes smoothly. Have clear directions and set relevant objectives. Ask yourself some questions like:
“Who do I want to network with?”
“Which of my products or services do I want to market?”
“How will I sell myself to others?”
The answers to your question will help define what you want to achieve.
Furthermore, ensure you plan financially, as attending this annual meeting can be costly. Make budgets for travel, accommodation, registration fees, and training of staff that will be present. The budget should also cover the cost of designing and printing promotional materials.
Pharmaceutical industries should make provisions for promotional materials such as business cards, brochures, and poster presentations. These materials should be detailed and easy to understand. Most leading solution providers also create a digital portfolio and make in-depth presentations for their companies. It will give an insight into what they do and their expertise in the drug discovery world.
How Can A Pharma Team Participate Actively During Conferences
pixabay.com
There are different means by which professionals can actively participate during a pharma conference. The following are some ways to maximize your experience and make your company stand out:
Speed Networking Sessions
Some conferences organize speed networking as a way to expand professional contacts. Though speed networking may come in different formats, they have the same end goal. With speed networking, attendees connect with people with like minds quickly.
Because of the limited time, it is important to prepare to make the most of speed networking. Before engaging, know what you want to say to avoid information overload. Greet other pharma professionals with a firm handshake, and introduce yourself and your company. You can start with ‘Hello, my name is ……., I work with ……. company, and I would like to connect with you’.
Furthermore, ask questions to ensure the conversation is two-way. You can write down the questions beforehand to get enough information. Don’t forget to take notes and exchange business cards at the convention center.
Not everyone meeting during an annual meeting will be a potential client or a great connector. Hence, make speed networking sessions as brief as possible and move to the next person.
Engaging Social Media Strategies
Social media can serve as a platform for you to engage your followers and leading researchers during and after the pharma summit. There is no doubt that Twitter and LinkedIn are the best social media platforms for marketing. However, as a global pharma company, you can try other platforms and expand beyond these two.
When using social media platforms:
Do not overshare and stick to valuable points.
Use relevant hashtags and tag the organizers to broaden your brand’s visibility.
You can also go live and share real-time updates to open discussion and engage your followers.
Reach out to as many attendees as possible, ask them to follow you and like your posts
You may also take pictures with other attendees and retweet their posts.
All these social media strategies will help the pharma industry connect to those with common interests.
Gamification: Turning Learning to Fun
Companies often pay for spaces and stands to showcase their products and services during an annual meeting. Pharma professionals show interest by visiting your stand and checking out your display. Talking at length about your brand might bore them, which makes it important to include games, challenges, and quizzes to make learning more fun.
You can group the participants and give them topics related to your company to brainstorm on. After that, ask questions and give rewards to winning teams.
Leading pharmaceutical companies also play quick-fire questions. This game involves two parties: a sales rep and an attendee. The sales rep has a limited time, mostly one minute, to ask questions, and the attendee answers immediately and vice versa.
You can ask questions like:
‘What is your job title?’
‘What three words describe you?’
‘What are your usual work hours?’
Asking these questions will enable both parties to know each other better.
Personalized Interactions: One-on-one Meetings
You can also create personalized content for your target audience to make them feel more valued. This is feasible when you can access the list of guests and all medical professionals. Here, you know those you want to meet and the exact message to pass across to sell yourself.
To do this,
Conduct thorough research based on the guests’ lists and identify your target audience.
Gather data on your target audience to understand them better
Using this data, tailor content to suit each client’s needs
Reach out in advance and schedule meetings to discuss medical affairs.
During the meetings, pitch yourself in the best way possible.
Follow up and maintain the relationship.
Attend Interactive Sessions
Focus on interactive sessions in conferences where you can engage other medical professionals actively. Some conferences organize panel discussions where experts explore particular topics. Participate actively in panel discussions when topics related to your company are the subject of the matter.
As pharmaceutical scientists, you should always ask questions during Q&A sessions. Also, give intelligent answers when keynote speakers throw questions to the audience.
Furthermore, don’t shy away from round tables and group discussions. Organizers in a strategic conference may divide attendees into smaller and more intimate groups in the convention center. People get to know each other, brainstorm on topics, and ask questions.
In this scenario, you can nominate yourself as the group leader to be actively involved. As the group leader, you will report your group’s findings to the larger audience. This way, you can sell yourself and your brand.
How Does A Pharmaceutical Company Stay Relevant After a Conference in 2025?
pixabay.com
A pharma company has only completed 50% of the task after successfully attending the pharma summit, as a lot still needs to be done. It is important to follow up on industry-critical conversations to build stronger and long-lasting relationships. Here’s how a biopharmaceutical industry can leverage connections
Sort out the business cards and contacts you collected.
Prioritize those that are more relevant and valuable to your business.
Send personalized messages explaining why you want to continue the conversation.
Set up a meeting, which can be virtual or in person, for further conversation.
During the meeting, tell them how your products and services can solve problems. Make your points concise.
Express gratitude for the time spent and store the customer info on your CRM software.
Stay active on social media and keep attending relevant conferences.
Tracking Outcomes of Pharmaceutical and Life Sciences Companies Marketing Efforts
Attending pharmaceutical sciences conferences is expensive, and it is important to make the most of it. The following are some ways a healthcare industry can check how well it maximizes pharma conferences
Review your Goals
Review your networking goals and objectives. Check how far you achieved each goal after the conference. This will give an insight as to how well you performed. For goals that were not met, analyze the reason that could have been behind them and work on it towards the next conference.
Personal Growth
Though the conference was mainly for marketing your brand, you should assess how it has driven your growth as an individual. Professional interactions can help sharpen your communication skills and increase your confidence.
Return on Investment
Measuring ROI using key performance indicators will give an insight into how profitable attending the pharma summit was. Compare your financial investments to the connections gained. It may also include business opportunities and collaborations.
Referrals and Recommendations
Referrals and recommendations tell you how well your new contacts are pleased with your services. This means that they understand what your pharmaceutical and biopharmaceutical industry do and trust you to deliver.
How A Pharmaceutical Company Can Maximize Virtual Conference Engagement in 2025
freepik.com
Attending virtual meetings is similar to physical conferences, and the difference is just the platform. There is this common belief that this digital innovation may not be effective in networking and meeting people. This is false, as virtual events may have enhanced networking features such as chat boxes, instant messaging, and live activity feeds.
The following are some ways one can maximize virtual conference engagement for easy market access
Like physical meetings, plan when attending virtual conferences and participate actively in relevant discussions.
Make use of the conference app if available. Go through the profiles of attendees and reach out to like-minded healthcare professionals. However, you may not find enough information, as data privacy in healthcare is a major concern in health systems.
Share updates on social media and participate in interactive sessions.
Join group chats and discussions to get to know other participants better.
Use CRM software to follow up with these professionals for a long-lasting relationship efficiently.
Final Thoughts
A pharma conference provides a medium where like-minded professionals can network, interact, and share ideas. Without proper planning, you may not have an amazing conference experience.
Before attending any pharmaceutical science conference, for example; research and development or drug delivery and drug discovery, it is important for healthcare professionals to write the networking goals they want to achieve and have strategic plans to achieve them. Since many of these conferences involve sharing and exploring data, it’s a plus to have reliable data-cleaning software that would preserve the genuity of your results
Furthermore, proper engagement is not limited to physical interactions, as the pharma industry can also attend conferences virtually. With our CRM software, companies can retain connections with healthcare professionals easily for business development.
Stay ahead of your competitors by following our Youtube and LinkedIn channels.
The pharmaceutical industry started its digital journey years ago, venturing into various technological advancements. This thrilling journey has been marked by constant evolution, introducing innovative technologies and reshaping the industry. With each passing year, new horizons emerge, promising exciting possibilities for the future of Pharma marketers.
The journey of Pharma’s digital transformation has been nothing short of captivating, but the story is far from over. Pharma advertising stands at the threshold of an even more exciting chapter. What lies ahead in the upcoming years? Join us in exploring the Pharma marketing future as we unveil the extraordinary evolution to redefine Pharma in 2025.
Stefan Repin, Head of Marketing of Platforce, and Adam Rosenberg, Senior Director of Marketing of RxLightning uncovers innovative marketing strategies, and share valuable tips for navigating the pharmaceutical landscape. Brace yourselves, for the future holds boundless potential.
Before the advent of digital technology, pharmaceutical industries operated using traditional marketing practices. Research and development (R&D) efforts were underway, and sales processes moved forward steadily. However, pharma advertising agencies faced limitations that were not immediately apparent until the introduction of technology.
In the early days, pharmaceutical record-keeping primarily relied on paperwork. There were no virtual pharma marketers or digital tools to promote products. The industry was yet to harness the power of digital technology, which would eventually change various aspects of pharmaceutical campaigns.
As technology started to permeate every sector, including healthcare, pharmaceutical companies began to explore the vast potential of digital solutions to enhance their processes, sales, and overall efficiency. This marked the beginning of the digital pharma era.
Transformation of Pharma Marketing Industry in the Digital Age
The digitization of the pharmaceutical industry opened doors to a new era, marked by the integration of computers and the Internet into various systems. This transition signifies a shift from manual, labor-intensive processes to automated, streamlined systems.
In the digital age of the Pharma market, numerous opportunities have emerged, changing how data is recorded, stored, and utilized.
Benefits of Digitalization
One of the key benefits of digitization is the precise record-keeping it offers. Pharmaceutical marketers can now document their campaign processes, ensuring every step is accurately recorded. This documentation process provides a valuable resource, allowing professionals to revisit and review procedures whenever necessary.
By having detailed records readily accessible, pharma marketers can learn from past experiences, make improvements, and avoid repeating errors. This capability for continuous improvement is an advantage brought about by the digital age.
Moreover, digitization has reduced the reliance on manual methods for pharma marketing campaigns. The introduction of computers at the onset of the digital age changed how information is managed. Instead of maintaining vast physical files and documents, all important data can now be stored electronically.
Patient Centricity in Digital Pharma Campaigns
The primary focus of pharma marketing campaigns has always been to provide medical care and treatments centered around the well-being of patients. Despite evolving digital trends, patients are the target audience for pharma marketers.
Regardless of the era, the fundamental objective remains the same: to create awareness of healthcare to empower patients. This era is marked by the notable improvement in patients’ health outcomes.
In today’s digital age, patients seek information that can enhance their overall well-being. Therefore, the marketing strategy must be customized to cater to the specific needs of patients.
Pharma marketers must ensure that digital campaigns effectively reach patients in an informative and engaging manner, aligning with the industry’s commitment to patient health.
Why Pharma Needs Digital Marketing Campaigns?
Aside from the fact that every business sector has been digitized, there are other factors to consider.
Most of the patients that are to be catered to use mobile phones and live in the digital age.
It is easier to reach a larger audience through social media strategies.
There are loads of information online, and digitizing medical information will make the pharma market stand out.
Patients follow digital trends, they expect the same from the pharma companies.
Helpful information should be made simple and engaging, not hidden.
It is necessary to make patients feel included in their health decisions.
Patients want access to information and be allowed to make decisions based on what they know.
Digital Campaign Strategies that Captivate Healthcare Audiences
freepik.com
Within the health sector, there is a challenge in determining the digital campaigns that resonate with the healthcare audience. There are different forms of campaigns, but not all of them are instrumental to Pharma marketers.
This is because the aim is not just to spread awareness and spark conversations but to promote health genuinely. Therefore, employing a strategy that prioritizes health promotion is important.
1. Social Media Campaigns
This method has become a prominent strategy in the pharmaceutical sector, frequently employed to raise awareness about different diseases and treatments. Given the widespread use of social media campaigns globally, it is the quickest means to spread information to a large audience.
In the current scenario, pharma marketers would miss a significant opportunity if they fail to leverage this platform. Therefore, social media campaigns are major game changers in any pharma industry.
2. Virtual Health Summits
Virtual Health Summits have emerged to address healthcare disparities across nations. Geographical distance often hinders traditional healthcare outreach efforts. Ensuring healthcare for everyone necessitates overcoming these geographical constraints.
Healthcare providers and patients must understand the contributions pharmaceutical industries can make in their communities. Virtual Summits have bridged this gap, enabling outreach to diverse audiences dealing with various diseases. With technology, people can convene from anywhere, anytime, breaking down barriers and promoting healthcare accessibility.
3. AI-Powered Personalised Medicine Campaigns
Artificial Intelligence (AI) acts as a healthcare superhero. It goes beyond human capabilities by collecting and comprehending vast patient data. This enables pharma marketers to offer personalized solutions, ensuring patients receive precisely what they need.
Thanks to AI, healthcare campaigns have become incredibly accurate and effective, transforming how information is provided to patients.
Digital Pharma in 2025: Virtual Reality (VR) and Augmented Reality (AR)
freepik.com
The potential of technology is limited, and it keeps getting better. But the pharmaceutical industry faces the challenge of integrating emerging technologies like Virtual Reality (VR) and Augmented Reality (AR) into healthcare.
Questions arise about the feasibility of implementation and patient acceptance, driving pharma marketing experts to explore innovative solutions in this evolving landscape.
Virtual Reality (VR) replicates real-world experiences in a digital environment, allowing users to engage with three-dimensional objects in a lifelike manner. Through VR, people can interact with three-dimensional objects using all their senses. Integrating this technology into pharma marketing is a leverage for how patients experience medical treatments. The benefits of Virtual reality in digital pharma campaigns include the following:
Patients become aware of how the drugs interact with their bodies.
This strategy encourages patients to become consistent with their medications.
It is an informative approach to pharma marketing.
Healthcare providers can identify the consequences of their medical decisions.
It builds trust and confidence in the products/therapies marketed to the audience.
Augmented Reality (AR) combines real-life experiences with virtual elements, blending the physical and digital worlds. It introduces 3D concepts into reality, blurring the lines between virtual and real experiences. AR is an interactive technology that merges reality with digital elements, bringing innovations into the tangible world. The intriguing question remains: how can this technology transform the pharmaceutical industry?
Patient education is now possible with AR.
Trials and errors are avoided with medical therapies.
Such campaign initiatives can help to spread awareness of the ailments to empower patients with accurate information.
It crafts experiences for healthcare providers and patients.
Also, patients stand at the core of every pharmaceutical endeavor, emphasizing the need for digital campaigns to cater exclusively to their needs. Acknowledging the potential of Augmented Reality and virtual reality, it becomes necessary for pharma marketers to adopt these technologies swiftly, ensuring a relevant impact on digital campaigns. The sooner these innovations are embraced, the greater the benefits for the entire pharma industry.
Example of a Collaboration that Changed the Pharma Industry
Novartis and Microsoft
In 2019, a collaboration between Novartis and Microsoft was unveiled, marking a significant leap toward healthcare transformation through Artificial Intelligence (AI). This partnership aimed not only to improve drug development but also to enhance the commercialization process.
Novartis recognized the role of technology in achieving its objectives, understanding that the complexities of healthcare demand innovative solutions beyond human capabilities.
Acknowledging the challenges pervasive in the healthcare sector, Novartis boldly partnered with AI, anticipating a future where technology would play a pivotal role in overcoming these challenges. The establishment of the AI innovation lab signaled Novartis’ strategic move to position itself at the forefront of the industry.
At the core of this AI-driven revolution is machine learning, a fundamental component of AI technology. Through machine learning algorithms, computers can analyze vast datasets, discern patterns, and identify trends.
This advancement has empowered Novartis to navigate the intricate healthcare system, paving the way for a promising and transformative future in the pharmaceutical sector.
Conclusion
In summary, digitization is the future of all pharmaceutical industrial operations. It involves the use of Pharma CRMs to streamline sales operations. Other incorporation of this cutting-edge technology into many pharma modus operandi are marketing campaigns, data security, market forecasting, and customer behavioral management.
Despite advancements in drug development, there are still constraints to human potential and in recognizing the opportunities technology offers, every pharmaceutical company can play an active part in improving the efficiency of their sales processes and results.
In this article, we’ve identified the endless possibilities of the digital age and how embracing its innovation is not just a choice but also a pathway to a vibrant, technologically-driven pharmaceutical future, and with our software as a key to that future.
